SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

IN THE PRESS
Press Releases
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
November 5, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
November 4, 2024
 · 
2 min read
Press Releases
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 24, 2024
 · 
4 min read
Press Releases
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
October 10, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
September 23, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
September 12, 2024
 · 
2 min read
Press Releases
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
August 22, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 15, 2024
 · 
7 min read
Press Releases
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
July 30, 2024
 · 
10 min read
Press Releases
CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
July 25, 2024
 · 
1 min read
Load More
JOBS